NDC 50222-360 – Spevigo
Spesolimab 60 mg/mL · Injection · Subcutaneous
Product NDC50222-360
Product details
- Brand name
- Spevigo
- Generic name
- Spesolimab
- Labeler
- LEO Pharma Inc.
- Dosage form
- Injection
- Route
- Subcutaneous
- Marketing category
- BLA · BLA761244
- Marketed since
- March 9, 2026
- Listing expires
- December 31, 2027
- Pharmacologic class
- Interleukin-36 Receptor Antagonist
Active ingredients
- Spesolimab 60 mg/mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 50222-360-72 | 2 VIAL, GLASS in 1 CARTON (50222-360-72) / 7.5 mL in 1 VIAL, GLASS | Mar 9, 2026 |
Other Spevigo products
- 0597-0035 Spesolimab 60 mg/mL · Injection · Boehringer Ingelheim Pharmaceuticals, Inc.
- 0597-0620 Spesolimab 150 mg/1 · Injection · Boehringer Ingelheim Pharmaceuticals, Inc.
- 0597-7705 Spesolimab 300 mg/1 · Injection · Boehringer Ingelheim Pharmaceuticals, Inc.
- 50222-361 Spesolimab 150 mg/mL · Injection · LEO Pharma Inc.
- 50222-362 Spesolimab 300 mg/2mL · Injection · LEO Pharma Inc.